Susquehanna said United Health remains a core holding for healthcare investors despite tempered guidance following its in-line Q3 results. The firm continues to see the company well positioned to deliver for investors. Shares are Positive rated but price target lowered to $82 from $84.
- Health Care Industry
- United Health